Habib George S
Department of Medicine, Carmel Medical Center, Haifa, 34362, Israel.
Clin Rheumatol. 2009 Jul;28(7):749-56. doi: 10.1007/s10067-009-1135-x. Epub 2009 Feb 28.
The objective of this study was to review all the published articles in the English literature about the systemic effects of intra-articular corticosteroid injection (IACI) in humans. Reports were searched through Pubmed using the terms intraarticular or intra-articular and steroids, corticosteroids, or glucocorticosteroids up and including the year 2007. Reports were also located through references of articles. Only objective findings outside the injected joint were included. The overwhelming majority of the studies was done at the knee joint and in rheumatoid arthritis/juvenile idiopathic arthritis patients. Many of the studies were done on the hypothalamic-pituitary-adrenal axis. Serum cortisol decreased within hours with a nadir after usually 24-48 h following the IACI. Recovery to baseline takes 1-4 weeks and sometimes longer depending on the type and dose of IACI and on the number of injected joints. Serum cortisol levels were blunted following adrenocorticotropic hormone stimulation in a small proportion of patients following methylprednisolone acetate injection and more common following other preparations. IACI resulted in a transient increase in blood glucose levels over few days in controlled diabetic patients with knee osteoarthritis. Peak levels are around 300 mg%. IACIs are associated with reduction in inflammatory markers like C-reactive protein and erythrocyte sedimentation rate that start few days following the IACI and could last for months. The effect on inflammatory cytokines is immediate with significant decrease within hours. IACI may induce remission also in patients with oligo-/polyarthritis and/or in patients with extra-articular manifestations. Other metabolic, hematologic, vascular, allergic, visual, psychologic, and other effects were also reported.
本研究的目的是回顾英文文献中所有已发表的关于关节内注射皮质类固醇(IACI)对人体全身影响的文章。通过在Pubmed上使用“关节内”或“关节内”以及“类固醇”“皮质类固醇”或“糖皮质类固醇”等术语进行检索,检索截止到2007年。还通过文章的参考文献查找相关报告。仅纳入注射关节以外的客观研究结果。绝大多数研究是在膝关节以及类风湿关节炎/幼年特发性关节炎患者中进行的。许多研究针对下丘脑 - 垂体 - 肾上腺轴展开。关节内注射皮质类固醇后数小时内血清皮质醇下降,通常在24 - 48小时后达到最低点。恢复至基线水平需要1 - 4周,有时更长,这取决于关节内注射皮质类固醇的类型和剂量以及注射关节的数量。在少数接受醋酸甲泼尼龙注射的患者中,促肾上腺皮质激素刺激后血清皮质醇水平受到抑制,在使用其他制剂后更为常见。关节内注射皮质类固醇会使患有膝关节骨关节炎的糖尿病患者在数天内血糖水平短暂升高。峰值水平约为300mg%。关节内注射皮质类固醇与炎症标志物如C反应蛋白和红细胞沉降率的降低有关,这种降低在关节内注射皮质类固醇后数天开始,并可持续数月。对炎症细胞因子的影响是即时的,数小时内显著下降。关节内注射皮质类固醇也可能诱导寡关节炎/多关节炎患者和/或有关节外表现的患者病情缓解。还报告了其他代谢、血液学、血管、过敏、视觉、心理及其他方面的影响。